FeesSafety
Pluang+

Melrose Industries gains 72% upside potential after strong trading update and new contracts, says RBC.

Market News
20 Nov 2026, 02:14 WIB
Proactive Investors
View Source
Bullish
Melrose Industries gains 72% upside potential after strong trading update and new contracts, says RBC.

RBC Capital Markets maintains an 'outperform' rating on Melrose Industries with an 800p price target, implying a 72% upside from current levels. The positive trading update highlights robust trading, new business wins, and progress in resolving production issues at Garden Grove. Melrose secured long-term contracts with Saab and GE, and expects Garden Grove to return to full production by early 2027. RBC also notes improved financing terms and forecasts strong free cash flow by 2029, supporting the bullish outlook.

Melrose's trading update and RBC's outlook provide context for market watchers. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Nov 20, 2026 06:42 WIB: of 135 priced US Industrials stocks, 13 rose and 121 fell. Notable movers include UPWK at USD 8.71 (-6.14%), SPCE at USD 1.13 (-5.83%) with 89% buy order activity, and RDW at USD 6.43 (-5.72%).

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App